Latest Strategy News

Pure Foods Tasmania reports a significant operational turnaround in 1H FY26, driven by strategic cost reductions, expanded distribution deals with major retailers, and the acquisition of premium ice cream brand Elato.

OD6 Metals has secured an exclusive option to acquire the Quinn Fluorspar Project in Nevada, boasting ultra high-grade deposits critical to US supply chains. The move complements its rare earth and copper assets, backed by a $3.4 million capital raise.

The Calmer Co. International Limited’s Fiji subsidiary has secured a FJ$548k non-repayable grant to expand ready-to-drink production and upgrade supply chain infrastructure, accelerating its growth without diluting shareholder equity.

Horizon Gold Limited has raised A$30 million through a placement and entitlement offer to accelerate exploration and advance the feasibility study at its Gum Creek Gold Project in Western Australia.

Great Southern Mining has commenced co-funded diamond drilling at two promising Western Australian targets, aiming to unlock platinum group elements and high-grade gold mineralisation.

PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.

Mach7 Technologies has completed its on-market share buy-back, acquiring over six million shares at an average price well below the initial $5 million cap. The move signals a cautious but confident approach to capital management amid evolving market conditions.

Theta Gold Mines has entered Phase 2 of construction at its TGME Gold Project, signing major contracts for structural, mechanical, platework, and piping works. The modular construction approach aims to cut costs and speed up delivery, targeting over 100,000 ounces of gold production annually.

Brightstar Resources has completed a US$120 million senior secured bond issue, complementing a recent A$193 million equity raise, to fully fund its Goldfields Project and advance the Sandstone Project towards final investment decision.

Island Pharmaceuticals has entered a pivotal research agreement with USAMRIID and the Geneva Foundation to accelerate FDA approval of Galidesivir for Marburg Virus Disease, leveraging top-tier US biodefense expertise.

Australian Vanadium Limited has raised $7.5 million through a targeted placement to accelerate its vertically integrated vanadium strategy, including the Kalgoorlie battery energy storage project.

Caprice Resources has identified four promising new gold targets south of its Vadrians deposit at the Island Gold Project, following initial air core drilling results. These findings pave the way for deeper drilling and potential resource expansion.